Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy
Thromb Haemost
.
2020 Sep;120(9):1343-1345.
doi: 10.1055/s-0040-1713637.
Epub 2020 Jul 9.
Authors
Emmanuel Weiss
1
2
3
,
Olivier Roux
4
,
Jean-Denis Moyer
1
,
Catherine Paugam-Burtz
1
2
,
Larbi Boudaoud
5
,
Nadine Ajzenberg
6
7
,
Dorothée Faille
6
7
,
Emmanuelle de Raucourt
5
7
Affiliations
1
Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP.Nord, Paris, France.
2
Inserm UMR_S1149, Inserm et Université de Paris, Paris, France.
3
EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure, EF CLIF, Barcelona, Spain.
4
Hepatology & Liver Intensive Care Unit, Hôpital Beaujon, Paris, France.
5
Service Hématologie Biologique, Hôpital Beaujon, Paris, France.
6
Laboratoire d'hématologie, APHP, Hôpital Bichat, Paris, France.
7
UMR_S1148, Inserm et Université de Paris, Paris, France.
PMID:
32645725
DOI:
10.1055/s-0040-1713637
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
Blood Coagulation Disorders*
COVID-19
Coronavirus Infections*
Fibrinolysis
Humans
Intensive Care Units
Pandemics*
Pneumonia, Viral*
Respiratory Insufficiency*
SARS-CoV-2
Thrombophilia*